"Tailored" antiplatelet bridging therapy with cangrelor: moving toward personalized medicine.
Platelets
; 33(5): 687-691, 2022 Jul 04.
Article
in En
| MEDLINE
| ID: mdl-34672898
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Platelet Aggregation Inhibitors
/
Purinergic P2Y Receptor Antagonists
Type of study:
Clinical_trials
/
Guideline
/
Prognostic_studies
Limits:
Humans
Language:
En
Journal:
Platelets
Journal subject:
HEMATOLOGIA
Year:
2022
Type:
Article
Affiliation country:
Italy